Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $985.99, with a 24-hour trading volume of $1.83B. The asset's market cap is $880.48B, after moving 0.72% in the last day.
Tokenized Eli Lilly And Co is trading at $989.62, with a tokenized market cap of $5.51M and a 24-hour trading volume of $2.13M. The tokenized asset has moved 3.65% in the past 24 hours.